Addressing the ethical issues raised by synthetic human entities with embryo-like features
- PMID: 28494856
- PMCID: PMC5360441
- DOI: 10.7554/eLife.20674
Addressing the ethical issues raised by synthetic human entities with embryo-like features
Erratum in
-
Correction: Addressing the ethical issues raised by synthetic human entities with embryo-like features.Elife. 2017 Apr 13;6:e27642. doi: 10.7554/eLife.27642. Elife. 2017. PMID: 28494857 Free PMC article. No abstract available.
Abstract
The "14-day rule" for embryo research stipulates that experiments with intact human embryos must not allow them to develop beyond 14 days or the appearance of the primitive streak. However, recent experiments showing that suitably cultured human pluripotent stem cells can self-organize and recapitulate embryonic features have highlighted difficulties with the 14-day rule and led to calls for its reassessment. Here we argue that these and related experiments raise more foundational issues that cannot be fixed by adjusting the 14-day rule, because the framework underlying the rule cannot adequately describe the ways by which synthetic human entities with embryo-like features (SHEEFs) might develop morally concerning features through altered forms of development. We propose that limits on research with SHEEFs be based as directly as possible on the generation of such features, and recommend that the research and bioethics communities lead a wide-ranging inquiry aimed at mapping out solutions to the ethical problems raised by them.
Keywords: 14 day rule; Embryo and stem cell ethics; developmental biology; stem cells; tissue engineering.
Conflict of interest statement
GMC: George Church is actively involved with companies commercializing synthetic biology. His financial interests are specified on his website: http://arep.med.harvard.edu/gmc/tech.html. Additionally, this article was supported by two grants from the NIH (Grants RM1HG008525 and P50HG005550). George Church is a founder and has a financial interest in two companies, Editas and ReadCoor, that are related to those grants. Additionally, potentially relevant patents to this article have been submitted. The companies have not had a role in the study design, data collection and analysis, decision to publish or preparation of the present manuscript.
The other authors declare that no competing interests exist.
Figures

Similar articles
-
Modelling human embryogenesis: embryo-like structures spark ethical and policy debate.Hum Reprod Update. 2020 Nov 1;26(6):779-798. doi: 10.1093/humupd/dmaa027. Hum Reprod Update. 2020. PMID: 32712668 Review.
-
How to Rethink the Fourteen-Day Rule.Hastings Cent Rep. 2017 May;47(3):5-6. doi: 10.1002/hast.698. Hastings Cent Rep. 2017. PMID: 28543424
-
Research on human-animal entities: ethical and regulatory aspects in Europe.Stem Cell Rev Rep. 2009 Sep;5(3):181-94. doi: 10.1007/s12015-009-9079-8. Epub 2009 Jun 26. Stem Cell Rev Rep. 2009. PMID: 19557551 Review.
-
Embryo experimentation: is there a case for moving beyond the '14-day rule'.Monash Bioeth Rev. 2020 Dec;38(2):181-196. doi: 10.1007/s40592-020-00117-x. Monash Bioeth Rev. 2020. PMID: 32737832
-
How and Why to Replace the 14-Day Rule.Curr Stem Cell Rep. 2018;4(3):228-234. doi: 10.1007/s40778-018-0135-7. Epub 2018 Jul 16. Curr Stem Cell Rep. 2018. PMID: 30148047 Free PMC article. Review.
Cited by
-
Revisiting selected ethical aspects of current clinical in vitro fertilization (IVF) practice.J Assist Reprod Genet. 2022 Mar;39(3):591-604. doi: 10.1007/s10815-022-02439-7. Epub 2022 Feb 22. J Assist Reprod Genet. 2022. PMID: 35190959 Free PMC article. Review.
-
Rearranging Deck Chairs on a Sinking Ship? : Some Reflections on Ethics and Reproduction Looking Back at 2017 and Ahead at 2018.J Bioeth Inq. 2018 Mar;15(1):7-13. doi: 10.1007/s11673-018-9840-2. Epub 2018 Jan 26. J Bioeth Inq. 2018. PMID: 29374386 No abstract available.
-
How to talk about genome editing.Br Med Bull. 2018 Jun 1;126(1):5-12. doi: 10.1093/bmb/ldy015. Br Med Bull. 2018. PMID: 29697749 Free PMC article.
-
Adapting the 14-day rule for embryo research to encompass evolving technologies.Reprod Biomed Soc Online. 2020 Jan 21;10:1-9. doi: 10.1016/j.rbms.2019.12.002. eCollection 2020 Jun. Reprod Biomed Soc Online. 2020. PMID: 32154395 Free PMC article.
-
Merits and challenges of iPSC-derived organoids for clinical applications.Front Cell Dev Biol. 2023 May 26;11:1188905. doi: 10.3389/fcell.2023.1188905. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37305682 Free PMC article. Review.
References
-
- Al-Chaer ED. Neuroanatomy of Pain and Pain Pathways. In: Moore R. J, editor. Handbook of Pain and Palliative Care. New York: Springer-Verlag; 2012. pp. 273–294.
-
- Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR. Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science. 2015;348:36–38. doi: 10.1126/science.aab1028. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources